Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Y Basham

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cancer Research|August 1, 1988
Comparison of combinations of interferons with tumor specific and nonspecific monoclonal antibodies as therapy for murine B- and T-cell lymphomasT Y Basham, M A Palladino, C C Badger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1988
Synergistic antitumor activity with IFN and monoclonal anti-idiotype for murine B cell lymphoma. Mechanism of actionT Y Basham, E R Race, M J Campbell, et al.
Cancer Research|August 1, 1989
Enhanced in vivo therapeutic response to interferon in mice with an in vitro interferon-resistant B-cell lymphomaT R Reid, E R Race, B H Wolff, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cancer Research|August 1, 1988
Comparison of combinations of interferons with tumor specific and nonspecific monoclonal antibodies as therapy for murine B- and T-cell lymphomasT Y Basham, M A Palladino, C C Badger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1988
Synergistic antitumor activity with IFN and monoclonal anti-idiotype for murine B cell lymphoma. Mechanism of actionT Y Basham, E R Race, M J Campbell, et al.
Cancer Research|August 1, 1989
Enhanced in vivo therapeutic response to interferon in mice with an in vitro interferon-resistant B-cell lymphomaT R Reid, E R Race, B H Wolff, et al.
Pageof 3